If you have followed the policy news, you may have heard of the BALANCE Model originally meant to pair medication access with mandatory lifestyle programs
Most patients on the out-of-pocket pathway either transition to a maintenance strategy (lower dose, less frequent injections) after initial weight loss or switch to compounded alternatives
Tirzepatide (Mounjaro / Zepbound) is used to promote weight loss and treat Type 2 diabetes through the GIP and GLP-1 receptor pathways
Rarely, slight difficulty sipping through a straw or pronouncing certain words may occur, but this is temporary
Log any of the 18 most common GLP-1 side effects - nausea, constipation, heartburn, fatigue, food noise, and the rest - plus unlimited custom symptoms, each on a 0-10 severity scale with a timestamp